No Result

View All Result

No products in the cart.

Home StudyGraphics

#VisualAbstract: Trastuzumab does not improve survival in patients with esophageal adenocarcinoma with HER2 overexpression

byTeddy Guo

April 27, 2022

in StudyGraphics

Reading Time: 1 min read

Click to read this study in The Lancet Oncology.

RELATED REPORTS

Simvastatin (Zocor) in combination with paclitaxel (Taxol) may provide treatment benefit compared to paclitaxel alone for small cell lung cancer

Pyrotinib provides survival benefit in human epidermal growth factor receptor 2-positive metastatic breast cancer when combined with trastuzumab and docetaxel

Camrelizumab may be safe and effective in the management of locally advanced esophageal squamous cell carcinoma

Risks associated with nonoperative management of uncomplicated pediatric appendicitis

RelatedReports

Thoracic radiotherapy improves survival in small-cell lung cancer patients

Chronic Disease

Simvastatin (Zocor) in combination with paclitaxel (Taxol) may provide treatment benefit compared to paclitaxel alone for small cell lung cancer

April 15, 2026

Variability in interpretation of breast biopsy slides associated with low verification of atypia and ductal carcinoma in situ

Chronic Disease

Pyrotinib provides survival benefit in human epidermal growth factor receptor 2-positive metastatic breast cancer when combined with trastuzumab and docetaxel

March 23, 2026

Hybrid minimally invasive esophagectomy associated with lower complication rates compared to open esophagectomy

Chronic Disease

Camrelizumab may be safe and effective in the management of locally advanced esophageal squamous cell carcinoma

March 19, 2026

Age and breast cancer risk factors associated with false-positive mammography results

Chronic Disease

The addition of a carboplatin to standard of care adjuvant chemotherapy improves survival outcomes in patients with high-risk, early-stage triple-negative breast cancer

January 12, 2026

Few older adolescents meet recommended levels of physical activity

Wellness Check: Exercise

#VisualAbstract: Neoadjuvant nivolumab plus chemotherapy increases event-free survival in resectable non-small-cell lung cancer

Abusive head trauma results in fewer productive life-years

Antenatal corticosteroids may affect neurodevelopment differently based on gestational age

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

No Result

View All Result